| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |